Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

SineuGene Therapeutics

Request full access

Biopharmaceutical company specializing in gene therapy for brain disorders, leveraging research from Tsinghua University's School of Medicine, and focusing on new AAV capsid variations for CNS gene…

ChinaFounded 2021Biotech & Life Sciences

About SineuGene Therapeutics

SineuGene Therapeutics is a biopharmaceutical company specializing in gene therapy for brain disorders. Founded in late 2021, the company leverages over a decade of neuroscience research from JiaLab at Tsinghua University's School of Medicine. SineuGene focuses on developing effective and safe gene therapy solutions for patients suffering from neurodegenerative diseases. The company has established a comprehensive platform for developing central nervous system (CNS) small nucleic acid drugs, which includes target screening, sequence design optimization, nucleic acid synthesis, chemical modifications, and delivery technology development. SineuGene collaborates with PackGene to screen for new AAV capsid variants specifically targeting the CNS, aiming to accelerate gene therapy advancements. The business model revolves around extensive research and development, clinical trials, and partnerships to bring innovative therapies to market. Revenue is generated through the development and commercialization of gene therapy products, as well as potential licensing agreements and collaborations with other biopharmaceutical companies.

Source: Dealroom company data

At a glance

Status
Operational
Employees
1
Open positions
None listed
Dealroom signal
25.3/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotechnology, Spinout, Biotech and Pharma, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEED✓Equity / VC Aug 2024 $14M $55M Transfar Chemicals · Sanmei Investment · Zhongguancun Development Group · Zhongbo Juli ↗
SEED✓Equity / VC Oct 2023 $2.8M $46M Beige Capital ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

SineuGene Therapeutics website traffic

Latest recorded traffic for SineuGene Therapeutics is 980 monthly website visits, down 2% over the last three months. SineuGene Therapeutics's team grew 0% over the past year.

Latest monthly visits980 3-month web change-2% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

SineuGene Therapeutics in its local ecosystem

Live from Dealroom

The SineuGene Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

8 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed7 investors entered at this stage

  • Shanghai Fengcang Innovation Fund
  • MSA Capital
  • Beige Capital
  • Zhongguancun Development Group
  • Transfar Chemicals
  • Sanmei Investment
  • Zhongbo Juli

Other known investors1 additional known investor

  • Tsinghua University
Employees 1 total headcount
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇨🇳 China100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about SineuGene Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See SineuGene Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.